Neoplasms: all 9,617 studies

Page 68 of 97. Open to participants first (2,509), then studies with results posted, then the rest; newest registration first within each.

• A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid TumorsCompletedNCT02955251Phase 1
• A Safety Study of SGN-2FF for Patients With Advanced Solid TumorsTerminatedNCT02952989Phase 1
• Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in WaldenstromActive, not recruitingNCT02952508Phase 2
• Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor PatientsTerminatedNCT02950103Phase 2
• A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA MutationsStatus unknownNCT02950064Phase 1
• Effectiveness of Nefopam in Breast Cancer SurgeryStatus unknownNCT02949310Not applicable
• A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma PatientsStatus unknownNCT02948699Phase 4
• A Phase I Study of TQ-B3395 on Tolerance and PharmacokineticsTerminatedNCT02944864Phase 1
• Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised PatientsStatus unknownNCT02944045Phase 3
• Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETsTerminatedNCT02943733Phase 1
• Checklist Tool in Engaging Patients in the Discharge Planning ProcessCompletedNCT02942524Not applicable
• Study of Ixazomib and Erlotinib in Solid TumorsCompletedNCT02942095Phase 1
• A Study of SC10914 in Patients With Advanced Solid TumorsStatus unknownNCT02940132Phase 1
• Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid TumorsTerminatedNCT02938793Phase 2
• Efficacy of Partial Covered Double Bare Metal Stent Compared to Uncovered Double Bare Metal Stent in Malignant Biliary ObstructionStatus unknownNCT02937246Not applicable
• Stereotactic Ablative Body Radiotherapy (SABR) for OligometastasesActive, not recruitingNCT02933242Not applicable
• Anti-mesothelin CAR T Cells for Patients With Recurrent or Metastatic Malignant TumorsStatus unknownNCT02930993Phase 1
• Chimeric Switch Receptor Modified T Cells for Patients With PD-L1+ Recurrent or Metastatic Malignant TumorsStatus unknownNCT02930967Phase 1
• Feasibility of Home vs. Hospital Based Resistance Training for Advanced Cancer PatientsCompletedNCT02930876Phase 2
• A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors.CompletedNCT02925104Phase 1
• Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced MalignancyCompletedNCT02925000Phase 1/2
• Study to Assess Osimertinib in Patients w/ Adv Solid Tumours & Normal Kidney Function or Severe Kidney ImpairmentCompletedNCT02923947Phase 1
• Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid TumorsCompletedNCT02923466Phase 1
• Imiquimod Treatment of High-grade CINStatus unknownNCT02917746Not applicable
• Kanitinib in Treating Patients With Advanced Solid TumorsCompletedNCT02916095Phase 1
• EpCAM CAR-T for Treatment of Advanced Solid TumorsActive, not recruitingNCT02915445Phase 1
• Lenvatinib and Capecitabine in Patients With Advanced MalignanciesWithdrawnNCT02915172Phase 1
• Expectations Regarding Mobility and Self-CareActive, not recruitingNCT02911064
• Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid TumorsCompletedNCT02909452Phase 1
• A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced CancersActive, not recruitingNCT02908906Phase 1/2
• Thermal Imaging for Evaluation of the CervixStatus unknownNCT02908607Phase 1/2
• Testing Use of Condoms on Regression of Cervical Intraepithelial NeoplasiaCompletedNCT02907333Not applicable
• Results From a Health System-wide Implementation of a Quality of Life QuestionnaireCompletedNCT02906423
• Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheetCompletedNCT02902107Phase 1
• Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary CancerCompletedNCT02900950Not applicable
• CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceTerminatedNCT02900248
• Study to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid TumorsCompletedNCT02900157Phase 1
• Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous ThromboembolismStatus unknownNCT02898051
• Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid TumorsCompletedNCT02897778Phase 1
• Osteoarticular Tumor Characterization by Advanced ImagingStatus unknownNCT02895633Not applicable
• CAR19 Donor Lymphocytes for Relapsed CD19+ Malignancies Following Allogeneic TransplantationCompletedNCT02893189Phase 1
• Performance and Evaluation for CT Colonography ScreeningCompletedNCT02892721Not applicable
• Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body FluidStatus unknownNCT02891642
• Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC PatientsCompletedNCT02891460Not applicable
• A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced CancersNo longer availableNCT02889445
• 18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After InterventionsTerminatedNCT02888301
• Thermal Testing in Bone Pain (TiBoP)CompletedNCT02887833
• A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid TumorsCompletedNCT02884128Phase 1
• MMRF Molecular Profiling ProtocolActive, not recruitingNCT02884102
• Dendritic Killer Cell-based Immunotherapy for Solid TumorsStatus unknownNCT02882659Phase 1
• Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive in Advanced Malignant Solid TumorsCompletedNCT02881190Phase 1
• A Study of RC48-ADC in Subjects With HER2-Positive Advanced Malignant Solid TumorsCompletedNCT02881138Phase 1
• The Role of Emotions and Regulatory Focus in Decision Making That Involves Risk TradeoffsWithdrawnNCT02874053
• Modification of the Quality of Life Based on Objective Geriatric TestsCompletedNCT02873533Not applicable
• PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid TumorStatus unknownNCT02873390Phase 1/2
• International Lung Screen Trial (ILST)Active, not recruitingNCT02871856Not applicable
• Clinical Trial on Acupuncture Therapy in Patients With Gastrointestinal Neoplasms Laparoscopic SurgeryStatus unknownNCT02871245Not applicable
• Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid TumorsCompletedNCT02867397Phase 1
• KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid TumorsCompletedNCT02867007Phase 1
• Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver MetastasesTerminatedNCT02866344Not applicable
• Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic IndicationsCompletedNCT02865889
• High Definition Endoscopy and Optic Enhancement Endoscopy in Gastric Neoplasia: A Prospective StudyStatus unknownNCT02863965
• Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of MNP Ph1-CompletedNCT02862366
• Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.CompletedNCT02862288Phase 1/2
• PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor (Lung, Liver and Stomach)Status unknownNCT02862028Phase 1/2
• Measuring the Effects of Therapeutic Education Program "Caratif" Patient Under Strong Opioids Versus Standard Taking Charge of Patient Pain Receiving Opioid Therapy in Medical Oncology.Status unknownNCT02862002Not applicable
• Detection and Characterization of Sessile Serrated Lesions (SSL) of the Right ColonStatus unknownNCT02861885
• Intra-peritoneal Chemotherapy in Ovarian CancerStatus unknownNCT02861872
• A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic CancerCompletedNCT02860780Phase 1
• Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)CompletedNCT02859623
• MASCT-I Treatment for Advanced Solid TumorStatus unknownNCT02858232Phase 1/2
• A Study of Hutchison MediPharma Limited(HMPL)-523 in Patients With Relapsed or Refractory Mature B-cell NeoplasmsCompletedNCT02857998Phase 1
• Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid TumorsCompletedNCT02857920Phase 1/2
• Study of JS001 in Participants With Advanced Solid TumorsCompletedNCT02857166Phase 1
• Impact of a Booklet-Question List on Cancer Patients or Their Families Seeking Prognostic Information During a Palliative Care ConsultationCompletedNCT02854293
• Natural History of and Specimen Banking for People With Tumors of the Central Nervous SystemCompletedNCT02851706
• Diagnostic Value of Optical Enhancement Technology in Early Esophageal Squamous NeoplasiaStatus unknownNCT02851264
• Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric OncologyCompletedNCT02847130
• Understanding Communication in Healthcare to Achieve Trust (U-CHAT)CompletedNCT02846038
• POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGCCompletedNCT02845908Phase 2
• The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage ICompletedNCT02845479Phase 3
• Study of CD133KDEL Toxin in the Treatment for Solid TumorsWithdrawnNCT02845414Phase 1
• Study of T Specific Immune Response Against Delta-CD20 Peptide in Hematological Malignancies BTerminatedNCT02844491
• Supplementation of L-arginine in Patients With Non-resectable Brain MetastasesCompletedNCT02844387Phase 1/2
• Combination of Cryosurgery and NK Immunotherapy for Advanced Liver CancerCompletedNCT02843802Phase 1/2
• Study of Inspiratory Muscle Training for Patients Undergoing Esophageal SurgeryWithdrawnNCT02843750Not applicable
• Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid TumorsCompletedNCT02843204Phase 1/2
• A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic NeoplasmsCompletedNCT02842229
• The Accuracy of Optic Biopsies Versus Conventional Biopsies for the Diagnosis of Superficial Bladder NeoplasiaStatus unknownNCT02841904Not applicable
• Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies.CompletedNCT02841124Not applicable
• Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1CompletedNCT02840058Not applicable
• Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary MetastasectomyWithdrawnNCT02839694Phase 1
• Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic CancerCompletedNCT02838381Not applicable
• Oncogeriatric Intervention and Follow-up at HomeStatus unknownNCT02837679Not applicable
• Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional StatusCompletedNCT02835937Not applicable
• Ceramide NanoLiposome in Patients With Advanced Solid TumorsCompletedNCT02834611Phase 1
• French National Registry of Rare Peritoneal Surface MalignanciesStatus unknownNCT02834169
• Difference of Gastric Microbiota in the Process of Correa's Model.Status unknownNCT02833363
• Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWithdrawnNCT02831179Phase 1
• Metastatic Tumor Research and Outcomes NetworkCompletedNCT02830451

← Neoplasms overview